About the Penn Pancreatic and Biliary Center
The Penn
Pancreatic and Biliary Center is one of the
busiest pancreatic surgery programs in the
United States. At the center, Penn physicians
are involved in the ongoing research and development
of new surgical techniques and new treatments
for diseases of the pancreas, bile duct, liver
and stomach.
It is estimated that more than 40,000 people in the United States will be diagnosed with pancreatic cancer this year. Unfortunately, the disease
is often associated with a high mortality rate.
For many patients, surgery is the best and most
successful treatment option.
Studies show that successful pancreatic cancer
surgery requires accurate diagnosis and surgeons
who are experienced in these complicated procedures.
Pancreas surgery is technically difficult and specialists at Penn Medicine perform among the highest volume of pancreatic operations in the Unites States, including the Whipple procedure, with complication rates and long-term survival statistics that set the standard nationally. As part of Penn's Abramson Cancer Center, patients also have facilitated access to the full range of treatment options for pancreatic cancer including radiation, chemotherapy and the latest clinical trials — all under one roof.
Advanced
Diagnostic Tools |
Along
with state-of-the-art surgical techniques,
Penn physicians have access to advanced
diagnostic tools such as endoscopic
ultrasound that can detect subtle
changes to the pancreas at an early
stage. |
|
Research and Development of New Surgical Techniques
Penn Medicine physicians participate in
the ongoing development of new surgical techniques
for these diseases and are conducting the research — from
fundamental molecular-based studies to translational
research on novel treatments — that is
advancing the field.
Learn more about Penn Medicine's involvement in Stand Up To Cancer
For more information about the Center, please
choose a topic below:
|
